DLA Piper's Pricing Rules

The Inflation Reduction Act Impacts on Pricing in the Life Sciences Industry

32 min · 23 de oct de 2024
Portada del episodio The Inflation Reduction Act Impacts on Pricing in the Life Sciences Industry

Descripción

David Hamilton facilitates a conversation with Lisa LeCointe-Cephas, partner and co-chair of the Life Sciences sector at DLA Piper, Kirsten Axelsen, senior policy advisor at DLA Piper, and Celeste Saravia, vice president at Cornerstone Research, on the impacts of the Inflation Reduction Act on innovation, competition, and pricing in the life sciences industry. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de DLA Piper's Pricing Rules!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

7 episodios

episode Algorithmic Pricing 2.0: Analyzing the intersection of AI and antitrust law artwork

Algorithmic Pricing 2.0: Analyzing the intersection of AI and antitrust law

In this episode of the Pricing Rules podcast, David Hamilton is joined by Greg Casas, Antitrust partner at DLA Piper, Joe Kendall, AI director in DLA Piper’s PiperAI team, Salil Mehra, a professor of antitrust law at Temple University, and Ai Deng, Managing Director at BRG. The panel examines how algorithmic pricing cases are evolving beyond the pleading stage in antitrust litigation, including how courts are analyzing motions to dismiss, what constitutes an “agreement” under Section 1 of the Sherman Act, and the growing role of expert testimony—both economic and technical—in evaluating algorithm design, data inputs, and alleged coordinated conduct. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

10 de abr de 202639 min